Posts

BMS CEO Boerner Says No Compulsion to Chase Deals Despite Quiet M&A Year

on

Legend Biotech CEO Ying Huang Resigns

on

Sarepta Taps Former AbbVie and Tessera CEO Michael Severino as New CEO to Lead Duchenne Drugmaker's Turnaround

on

Sanofi's R&D chief Ashrafian exits as new CEO Garijo seeks to fix pipeline with former Roche executive Fontoura

on

Pfizer hunts for new CFO as Denton prepares to leave for consumer goods sector

on

Moderna adds commercial chief, expands Stephen Hoge's role

on

Big Pharma’s 10 Highest-Paid CEOs of 2025: Key Figures and Compensation Ranges

on

Novartis CEO Calls for 'Complete Rethink' on Europe's Drug Pricing Policies

on

Pharmatech Associates Appoints Erika Porcelli as CEO

on

agilon health Appoints Tim O’Rourke as Chief Executive Officer

on

Merck KGaA AGM: Kai Beckmann Appointed CEO Effective May 1, 2026

on

Sanofi's Dupixent LCM Strategy Gains Prominence Amid Q1 2026 Success and Patent Defense Plans

on

BBOT Shakes Up Leadership as RAS Competitors Gain Visibility

on

Sanofi Defends Belén Garijo's CEO Appointment Amid R&D and Immunology Focus

on

PhRMA CEO Steve Ubl to Step Down at End of 2026

on

After Missing Kezar Buyout in 2024, Kevin Tang Returns as CEO of Aurinia with $50M Offer

on

Takeda Announces Leadership Transition with Julie Kim as New CEO Amid Organizational Changes

on

Aurinia Board Restructured: Kevin Tang Appointed Director Amid Shareholder Alignment, CEO Stays On

on

Infinity Bio Appoints Brian McKelligon as Chief Executive Officer

on

IsomAb Appoints Dr. Philip Brainin as Chief Executive Officer

on